These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19576214)

  • 1. Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.
    Budd S; Byfield G; Martiniuk D; Geisen P; Hartnett ME
    Exp Eye Res; 2009 Nov; 89(5):718-27. PubMed ID: 19576214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.
    Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME
    Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
    Wang H; Yang Z; Jiang Y; Hartnett ME
    Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
    Saito Y; Geisen P; Uppal A; Hartnett ME
    Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.
    McCloskey M; Wang H; Jiang Y; Smith GW; Strange J; Hartnett ME
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2020-6. PubMed ID: 23449716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
    Budd SJ; Thompson H; Hartnett ME
    Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo.
    Dan H; Lei X; Huang X; Ma N; Xing Y; Shen Y
    Microvasc Res; 2021 Jul; 136():104146. PubMed ID: 33610563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.
    Byfield G; Budd S; Hartnett ME
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3360-5. PubMed ID: 19264880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity.
    Hartmann JS; Thompson H; Wang H; Kanekar S; Huang W; Budd SJ; Hartnett ME
    Mol Vis; 2011; 17():1577-87. PubMed ID: 21738387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity.
    Ramshekar A; Bretz CA; Hartnett ME
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
    Hartnett ME; Martiniuk DJ; Saito Y; Geisen P; Peterson LJ; McColm JR
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4975-82. PubMed ID: 17065516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.
    Saito Y; Uppal A; Byfield G; Budd S; Hartnett ME
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1591-8. PubMed ID: 18385079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke.
    Shimotake J; Derugin N; Wendland M; Vexler ZS; Ferriero DM
    Stroke; 2010 Feb; 41(2):343-9. PubMed ID: 20101028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).
    Hartnett ME
    Trans Am Ophthalmol Soc; 2010 Dec; 108():96-119. PubMed ID: 21212851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.
    Budd SJ; Hartnett ME
    Arch Ophthalmol; 2010 May; 128(5):589-95. PubMed ID: 20457980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing Retinal Endothelial Glycolysis by Inhibiting UCP2 Promotes Physiologic Retinal Vascular Development in a Model of Retinopathy of Prematurity.
    Han X; Kong J; Hartnett ME; Wang H
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1604-1613. PubMed ID: 30995317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.
    Jiang Y; Wang H; Culp D; Yang Z; Fotheringham L; Flannery J; Hammond S; Kafri T; Hartnett ME
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):824-31. PubMed ID: 24425851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.
    Xie C; Wan X; Quan H; Zheng M; Fu L; Li Y; Lou L
    Cancer Sci; 2018 Apr; 109(4):1207-1219. PubMed ID: 29446853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.